GOLGA2P9

Across TCGA pan-cancer cohorts, GOLGA2P9 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated GOLGA2P9 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher GOLGA2P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA2P9 expression acts as an unfavorable survival marker, although some lineages such as LAML and SKCM show a favorable association.

DLBC, LAML, and SKCM are the cancer types where GOLGA2P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
LAML	DFS	Tertile	All	0.509	0.259	.012	22	view →
SKCM	OS	Tertile	III,IV	1.000	0.351	.007	21	view →
PAAD	OS	Tertile	II,III,IV	0.251	0.446	.015	18	view →
MESO	OS	Tertile	III,IV	0.738	0.192	.006	18	view →
BRCA	DFS	Tertile	All	0.479	0.539	.010	18	view →
KIRC	OS	Tertile	All	0.741	0.827	.033	15	view →
THYM	DFS	Tertile	All	0.480	0.804	.022	11	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
LUSC	DFS	Tertile	II,III,IV	0.527	0.803	.010	6	view →
PRAD	DFS	Tertile	All	0.724	0.781	.044	6	view →
ESCA	DFS	Median	III,IV	0.523	0.328	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

GOLGA2P9–DLBC (OS)

Open the DLBC breakdown →